Sequencing pioneer sets sights on $100 genome


Next-gen sequencing pioneer Illumina says it may soon usher in the era of the $100 genome — which could, in theory, make consumer genomics orders of magnitude more accessible.

CEO Francis deSouza…unveiled a new machine, called the NovaSeq, at…[the] J.P. Morgan Healthcare Conference in San Francisco. He said the machine’s scanning speed has increased to a pace that could unravel the DNA of an entire human genome in an hour.

Some caveats right off the bat: Even if it is that fast, it’ll still take much longer to actually interpret the data. And while deSouza promised the new machine is “expected one day” to allow for a genome to be sequenced for $100, the company isn’t quite there yet.

Nonetheless, the goal of $100 genome is tantalizing: Less than a decade ago, the cost of sequencing a full genome was several million dollars.


“Faster, inexpensive and innovative sequencing technology is a key component to driving breakthroughs in precision medicine,” Human Longevity founder J. Craig Venter said in a statement.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Illumina says it can deliver a $100 genome — soon

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend